Skip to main content
Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · IEX Real-Time Price · USD
3.550
+0.020 (0.57%)
At close: May 17, 2024, 4:00 PM
3.700
+0.150 (4.23%)
After-hours: May 17, 2024, 7:21 PM EDT

Repare Therapeutics Revenue

Repare Therapeutics had revenue of $97.86M in the twelve months ending March 31, 2024, down -28.62% year-over-year. Revenue in the quarter ending March 31, 2024 was $52.40M with 822.93% year-over-year growth. In the year 2023, Repare Therapeutics had annual revenue of $51.13M, a decrease of -61.21%.

Revenue (ttm)
$97.86M
Revenue Growth
-28.62%
P/S Ratio
1.54
Revenue / Employee
$546,698
Employees
179
Market Cap
151.11M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202351.13M-80.70M-61.21%
Dec 31, 2022131.83M124.23M1,634.61%
Dec 31, 20217.60M7.47M5,529.63%
Dec 31, 2020135.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CytomX Therapeutics 119.18M
Harvard Bioscience 106.79M
TELA Bio 63.15M
Electromed 53.50M
ProQR Therapeutics 14.66M
Syros Pharmaceuticals 6.98M
Sagimet Biosciences 2.00M
Revenue Rankings

RPTX News

More News